Last Price | 1.06 | Max Price | 2.20 |
Min Price | 1.05 | 1 Year return | -47.52 |
Avg. Target | 0.00 | Expected Return | -100.00 % |
Sector | Health Care | Subsector | Biotechnology |
Sell | 0 | Rating | |
Hold | 0 | Concensus | |
Buy | 0 |
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 11 | 141,925 | 0.01 % |
2020 | 9 | 170,231 | 0.01 % |
2021 | 11 | 252,886 | 0.00 % |
2022 | 32 | 238,496 | 0.01 % |
2023 | 0 | 0 | 0.00 % |
Date Label | Bank Label | Stock Label | Advice Label | Price Label | Diff Label |
---|---|---|---|---|---|
March 10, 2019 | Independent Research | Medigene | Hold | 10.00 | 73.10 % |
December 03, 2018 | Baader Bank | Medigene | Buy | 17.00 | 84.18 % |
November 29, 2018 | Independent Research | Medigene | Hold | 10.80 | 48.61 % |
August 12, 2018 | Independent Research | Medigene | Hold | 15.50 | 58.58 % |
May 28, 2018 | Independent Research | Medigene | Hold | 16.50 | 50.12 % |
April 02, 2018 | Baader Bank | Medigene | Buy | 22.00 | 62.14 % |
March 25, 2018 | Oddo BHF | Medigene | Hold | 13.00 | 79.31 % |
No Records Found
No Records Found
No Records Found
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
7
|
7
|
10
|
8
|
11
|
9
|
Costs |
20
|
17
|
26
|
29
|
31
|
38
|
Profit |
-13
|
-9
|
-16
|
-21
|
-20
|
-29
|
Margin of profit |
-190.90
|
-128.59
|
-155.24
|
-273.94
|
-187.77
|
-330.06
|
ROI |
-14.45
|
-12.08
|
-17.10
|
-20.56
|
-24.40
|
-54.34
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
90
|
79
|
94
|
103
|
82
|
53
|
Debt |
24
|
33
|
18
|
22
|
27
|
22
|
Total assets |
114
|
112
|
112
|
125
|
109
|
75
|
Solvency |
79.27
|
70.35
|
83.53
|
82.66
|
74.91
|
71.10
|
Cash |
9
|
15
|
28
|
27
|
35
|
30
|
Cashflow |
-11
|
-4
|
-21
|
-10
|
-16
|
-25
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
-0.45
|
-0.11
|
-1.13
|
-0.47
|
-0.60
|
-1.15
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
8.70
|
11.90
|
12.73
|
7.38
|
4.00
|
Eps |
-0.48
|
-0.74
|
-0.90
|
-0.81
|
-1.18
|
Price/earnings-ratio |
-18.12
|
-16.08
|
-14.14
|
-9.11
|
-0.90
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
3.90
|
4.19
|
4.20
|
3.33
|
2.16
|
Market to book |
0.45
|
0.35
|
0.33
|
0.45
|
2.04
|
Cashflow per stock |
-0.19
|
-0.93
|
-0.41
|
-0.67
|
-1.01
|
Stocks |
20
|
22
|
25
|
25
|
25
|
Market Cap |
175.19
|
265.38
|
312.61
|
181.27
|
26.04
|
Date
|
Price
|
---|---|
09 Jan 2025
|
1.06
|
17 Dec 2024
|
1.11
|
10 Dec 2024
|
1.08
|
06 Dec 2024
|
1.05
|
03 Dec 2024
|
1.11
|
29 Nov 2024
|
1.16
|
27 Nov 2024
|
1.40
|
13 Nov 2024
|
1.56
|
08 Nov 2024
|
1.54
|
05 Nov 2024
|
1.62
|
31 Oct 2024
|
1.65
|
29 Oct 2024
|
1.77
|
23 Oct 2024
|
1.87
|
19 Oct 2024
|
1.87
|
16 Oct 2024
|
2.01
|
14 Oct 2024
|
1.81
|
05 Oct 2024
|
2.11
|
02 Oct 2024
|
2.14
|
27 Sep 2024
|
2.00
|
20 Sep 2024
|
2.12
|
17 Sep 2024
|
2.08
|
13 Sep 2024
|
1.92
|
28 Aug 2024
|
1.10
|
26 Aug 2024
|
1.13
|
23 Aug 2024
|
1.14
|
11 Aug 2024
|
1.10
|
07 Aug 2024
|
1.09
|
05 Aug 2024
|
1.13
|
01 Aug 2024
|
1.11
|
30 Jul 2024
|
1.15
|